Tamsulosin Hydrochloride Capsule
Product Images NDC 76282-744

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 76282-744). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 2b (Figure 2b)

A line graph depicting the mean change in a measured variable over a treatment duration of up to 13 weeks plus last observation carried forward (LOCF). The graph compares three treatment groups: 0.8 mg, 0.4 mg, and placebo, showing mean changes on the y-axis and duration weeks on the x-axis, with sample sizes noted below the x-axis at various time points.*

FDA Label Image

Figure 3a.jpg (Figure 3a)

A line graph showing mean change over time in mL/sec for three groups: 0.8 mg Tamsulosin hydrochloride, 0.4 mg Tamsulosin hydrochloride, and placebo. The x-axis represents duration of treatment in weeks (0 to 13 weeks and LOCF), and the y-axis represents mean change in mL/sec from 0 to 3. Data points and trend lines compare the effects of the two dosage levels against placebo over the treatment duration.*

FDA Label Image

Figure 3b (Figure 3b)

Line graph showing mean change in flow rate (mL/sec) over duration of treatment in weeks for Tamsulosin hydrochloride at 0.8 mg and 0.4 mg doses compared with placebo. The x-axis represents weeks of treatment up to 13 weeks and LOCF, and the y-axis shows mean change in mL/sec, depicting higher increases for 0.8 mg dose over time compared to 0.4 mg and placebo groups.*

FDA Label Image

Figure 1 (Figure1)

A line graph depicting plasma concentration (ng/mL) of Tamsulosin hydrochloride over time (hours) up to 36 hours. Two curves compare drug levels under fasted (dashed line) and fed (solid line) conditions, showing variations in absorption or metabolism over time.*

FDA Label Image

Figure 2a (Figure2a.jpg)

A line graph showing mean change over duration of treatment (weeks) comparing three groups: 0.8 mg dosage, 0.4 mg dosage, and placebo. The Y-axis represents mean change, and the X-axis shows weeks of treatment from baseline to 13 weeks and LOCF (last observation carried forward). The 0.8 mg group shows the greatest negative mean change over time, followed by the 0.4 mg group and the placebo group.*

FDA Label Image

Label (Label)

Label for Tamsulosin Hydrochloride Capsules, USP 0.4 mg oral capsules, manufactured by Exelan Pharmaceuticals, Inc. The label includes dosage strength, storage instructions, warnings, and a quantity of 500 capsules. It features a barcode and emphasizes dispensing with the attached patient package insert.*

FDA Label Image

Structure (Str)

Chemical structure of tamsulosin hydrochloride showing the arrangement of its functional groups and aromatic rings, including the hydroxyethyl and methoxy substituents, and the hydrochloride ion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.